Is there autochthonous strongyloidiasis in Spanish children?

被引:0
作者
Jorge Bustamante
Sara Pérez-Muñoz
Talía Sainz
Milagros García Lopez-Hortelano
Dolores Montero-Vega
María José Mellado
机构
[1] Hospital General de Valdepeñas,Department of Pediatrics
[2] Ciudad Real,Department of Pediatrics
[3] La Paz Research Institute (IdiPAZ),General Pediatrics and Infectious and Tropical Diseases Department
[4] Universidad Autónoma de Madrid (UAM) and La Paz Research Institute IdiPaz,Microbiology Department
[5] Hospital de Torrejón,undefined
[6] La Paz University Hospital and La Paz Research Institute (IdiPAZ),undefined
[7] Red de Investigación Traslacional en Infectogía Pediatríca (RITIP) and La Paz Research Institute IdiPaz,undefined
[8] Hospital La Paz,undefined
[9] Red de Investigación Traslacional en Infectogía Pediatríca (RITIP) also Universidad Autónoma de Madrid and La Paz Research Institute IdiPaz,undefined
来源
European Journal of Pediatrics | 2021年 / 180卷
关键词
Strongyloidiasis; Children; intestinal parasites;
D O I
暂无
中图分类号
学科分类号
摘要
Strongyloidiasis, a neglected helminthiasis, is more prevalent in tropical/subtropical areas. However, sporadic autochthonous cases have been described around the Mediterranean coast. We performed a retrospective descriptive study in a referral Spanish Center for Pediatric Tropical diseases. All patients below 18 years of age diagnosed with probable strongyloidiasis between January 2014 and December 2019, born in Spain and with no history of travel abroad, were included. Epidemiological, clinical, and follow-up data were recorded, as well as all microbiology results. Five children met the inclusion criteria and were included in the study. Three males and two females, with a median age of 6.7 years (IQR: 5.8–9.1). All patients had previous medical conditions and used to spend holidays on the Mediterranean coast of Spain. All but one were mildly symptomatic at diagnosis but only four presented peripheral eosinophilia, which was the main reason for referral. First-line treatment was ivermectin in all but one, who was treated with albendazole. Reinfection was suspected in two during follow-up. At 12 months of follow-up 3/5 (60%) children presented negative serology.
引用
收藏
页码:1641 / 1645
页数:4
相关论文
共 45 条
  • [1] Buonfrate D(2020)The global prevalence of strongyloides stercoralis infection Pathogens. 9 1-9
  • [2] Bisanzio D(2014)The epidemiology of human strongyloidiasis Curr Trop Med Rep 1 216-222
  • [3] Giorli G(2019) infection: a systematic review of endemic cases in Spain PLoS Negl Trop Dis 13 e0007230-617
  • [4] Odermatt P(2020)Severe Strongyloides stercoralis infection in kidney transplant recipients: a multicenter case-control study PLoS Negl Trop Dis 14 e0007998-834
  • [5] Fürst T(2013)Severe strongyloidiasis: a systematic review of case reports BMC Infect Dis 13 78-undefined
  • [6] Greenaway C(2016)Eosinophilia Prim Care Clin Off Pract 43 607-undefined
  • [7] French M(2014)Usefulness of strongyloides stercoralis serology in the management of patients with eosinophilia Am J Trop Med Hyg 90 830-undefined
  • [8] Reithinger R(undefined)undefined undefined undefined undefined-undefined
  • [9] Gobbi F(undefined)undefined undefined undefined undefined-undefined
  • [10] Montresor A(undefined)undefined undefined undefined undefined-undefined